SEC Form 4 · accession 0001193125-26-330502

Apnimed, Inc. · APMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Dennis Patrick Molnar

Officer — President

Period of report

Jul 30, 2026

Accepted (ET)

Aug 3, 2026 · 4:01 pm EDT

Rule 10b5-1 plan

box not checked

Issuer CIK

0001745648

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class A Common Stock^F1	Aug 3, 2026	D	58,014	—	D	0	D
Common Stock^F1	Aug 3, 2026	A	58,014	—	A	58,014	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$1.00	Aug 3, 2026	D	330,210	D	—	Jan 24, 2029	Class A Common Stock	330,210	0	D
Stock Option (Right to Buy)^F2	$1.00	Aug 3, 2026	A	330,210	A	—	Jan 24, 2029	Common Stock	330,210	330,210	D
Stock Option (Right to Buy)^F2	$1.00	Aug 3, 2026	D	42,240	D	—	Jan 29, 2030	Class A Common Stock	42,240	0	D
Stock Option (Right to Buy)^F2	$1.00	Aug 3, 2026	A	42,240	A	—	Jan 29, 2030	Common Stock	42,240	42,240	D
Stock Option (Right to Buy)^F2	$1.06	Aug 3, 2026	D	148,788	D	—	Mar 31, 2030	Class A Common Stock	148,788	0	D
Stock Option (Right to Buy)^F2	$1.06	Aug 3, 2026	A	148,788	A	—	Mar 31, 2030	Common Stock	148,788	148,788	D
Stock Option (Right to Buy)^F2	$2.74	Aug 3, 2026	D	37,064	D	—	Jun 14, 2032	Class A Common Stock	37,064	0	D
Stock Option (Right to Buy)^F2	$2.74	Aug 3, 2026	A	37,064	A	—	Jun 14, 2032	Common Stock	37,064	37,064	D
Stock Option (Right to Buy)^F3	$4.00	Aug 3, 2026	D	28,539	D	—	Dec 22, 2032	Class A Common Stock	28,539	0	D
Stock Option (Right to Buy)^F3	$4.00	Aug 3, 2026	A	28,539	A	—	Dec 22, 2032	Common Stock	28,539	28,539	D
Stock Option (Right to Buy)^F4	$4.87	Aug 3, 2026	D	37,064	D	—	Dec 21, 2033	Class A Common Stock	37,064	0	D
Stock Option (Right to Buy) Stock Option (Right to Buy)^F4	$4.87	Aug 3, 2026	A	37,064	A	—	Dec 21, 2033	Common Stock	37,064	37,064	D
Stock Option (Right to Buy)^F5	$8.88	Aug 3, 2026	D	12,231	D	—	Sep 19, 2035	Class A Common Stock	12,231	0	D
Stock Option (Right to Buy)^F5	$8.88	Aug 3, 2026	A	12,231	A	—	Sep 19, 2035	Common Stock	12,231	12,231	D
Stock Option (Right to Buy)^F6	$16.00	Jul 30, 2026	A	55,596	A	—	Jul 29, 2036	Class A Common Stock	55,596	55,596	D
Stock Option (Right to Buy)^F6	$16.00	Aug 3, 2026	D	55,596	D	—	Jul 29, 2036	Class A Common Stock	55,596	0	D
Stock Option (Right to Buy)^F6	$16.00	Aug 3, 2026	A	55,596	A	—	Jul 29, 2036	Common Stock	55,596	55,596	D

Explanation of responses

F1Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
F2100% of the shares subject to such option are fully vested.
F325% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F425% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F525% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F6The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.